Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS44017322HTLV-1ENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS44009707HTLV-1ENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS44010838HTLV-1ENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS44031510HTLV-1ENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS44004962HTLV-1ENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS44013760HTLV-1ENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS44017324HTLV-1ENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS44023248HTLV-1ENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS44026585HTLV-1ENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS44034929HTLV-1ENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TCGA Plot Options
Drug Information
GeneKCNQ1
DrugBank IDDB04957
Drug NameAzimilide
Target IDBE0000672
UniProt IDP51787
Regulation Type
PubMed IDs11573692; 11060832
CitationsSchmitt H, Cabo C, Coromilas JC, Wit AL: Effects of azimilide, a new class III antiarrhythmic drug, on reentrant circuits causing ventricular tachycardia and fibrillation in a canine model of myocardial infarction. J Cardiovasc Electrophysiol. 2001 Sep;12(9):1025-33.@@Abrol R, Page RL: Azimilide dihydrochloride: a new class III anti-arrhythmic agent. Expert Opin Investig Drugs. 2000 Nov;9(11):2705-15.
GroupsInvestigational
Direct ClassificationHydantoins
SMILESCN1CCN(CCCCN2C(=O)CN(N=CC3=CC=C(O3)C3=CC=C(Cl)C=C3)C2=O)CC1
Pathways
PharmGKB
ChEMBL